Skip to main content

Slight Gain for BCW Index as Markets Recover

A week after the markets took a beating from investors, the BCW Index, along with blue chip and tech stocks, made gains for the week ended Tuesday. The BCW Index rose .6 percent, while the DJIA gained 2.5 percent and the Nasdaq rose 1.7 percent. The Nasdaq Biotech Index was flat for the tracking period.

Among the Index companies, Stratagene posted the biggest gain — 6.8 percent — as the firm's shares rebounded from a 52-week low of $5.65, reached on June 12. Applied Biosystems had a fairly strong week, finishing up 5.8 percent. Meanwhile, Bruker led decliners with a drop of 7 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(June 20, 2006)
Last Price
(June 13, 2006)
% change
Agilent
A
32.18
31.45
2.3
Applied Biosystems
ABI
30.50
28.84
5.8
Beckman
BEC
53.44
52.88
1.1
Bio-Rad
BIO
64.80
64.40
0.6
Bruker
BRKR
4.62
4.97
-7.0
Fisher Scientific
FSH
70.29
71.29
-1.4
GE
GE
33.70
33.73
-0.1
Harvard Bio
HBIO
4.09
4.16
-1.7
Invitrogen
IVGN
64.19
63.87
0.5
Molecular Devices
MDCC
28.42
27.85
2.0
PerkinElmer
PKI
20.40
20.55
-0.7
Qiagen
QGEN
13.20
12.98
1.7
Sigma
SIAL
70.03
68.89
1.7
Stratagene
STGN
6.25
5.85
6.8
Thermo
TMO
34.82
35.60
-2.2
Waters
WAT
41.66
41.82
-0.4
BCW Index Average
35.79
35.57
0.6
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.